News Sentiment

TDOC sentiment intelligence

Teladoc Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 53 Balanced news tone 56 relevant articles
Exchange NYSE United States
Sector Healthcare Market context
Industry Health Information Services Read-through group
Latest close 9.28 Week of 10 Jul 2026
Weighted tone 53/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

79/100 classification confidence.

Company focus 56

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend active

+0.9% over one week, +26.4% over four weeks, trend active, and near fair-value range.

Latest direct headline Neutral

Teladoc Health to announce Q2 2026 results on July 29

Market Reaction

Balanced read

51/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 79/100 classification
One-week reaction 0.9% Price digesting
Trend fit Trend active 26.4% over four weeks
Fair value -15.9% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 16
Neutral 32
Negative 8

Relevance

Why the article matched

Direct first
Direct company coverage 56
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Market source 11
simplywall.st 6
Stock Titan 5
TradingView 3
Simply Wall St. 3
Simply Wall Street 2
Investing.com 2
Sahm 2

Event Lens

What the news is about

Classified themes
Market update 30
Earnings 11
Deals and strategy 6
Analyst action 6
Balance sheet 2
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 56
scanx.trade Direct company coverage

Teladoc Health to announce Q2 2026 results on July 29

Teladoc Health Inc. is scheduled to release its second-quarter 2026 financial results on July 29, 2026, after market close. A conference call will follow at 5:00 p.m. ET to discuss these results, with dial-in and webcast details provided for interested investors. The company focu

Tone
Neutral 50/100
Event
Earnings
Published
15 Jul 2026 22:57
Source
scanx.trade
The Manila Times Direct company coverage

Teladoc Health to Announce Second Quarter 2026 Financial Results

Teladoc Health Inc. (NYSE: TDOC) announced it will release its second quarter 2026 financial results on Wednesday, July 29, 2026, after the market closes. The company will host a conference call on the same day at 5:00 p.m. ET to discuss the results, with details provided for att

Tone
Neutral 50/100
Event
Earnings
Published
15 Jul 2026 20:19
Source
The Manila Times
Stock Titan Direct company coverage

Teladoc Health to Release Q2 Results After Market Close

Teladoc Health (NYSE: TDOC) announced it will release its second quarter 2026 financial results on Wednesday, July 29, 2026, after market close. The company will host a conference call at 5:00 p.m. ET on the same day to review the results, with U.S. participants able to join by d

Tone
Neutral 50/100
Event
Earnings
Published
15 Jul 2026 20:19
Source
Stock Titan
Simply Wall Street Direct company coverage

Teladoc (TDOC) Stock May Be 39% Below Fair Value As Insurance Expansion Grows

Teladoc Health (TDOC) stock appears undervalued based on Discounted Cash Flow and sales multiples, despite a significant decline over the past five years. The company's intrinsic value is estimated to be 38.8% above its current share price, supported by projected free cash flow g

Tone
Positive 64/100
Event
Balance sheet
Published
15 Jul 2026 16:19
Source
Simply Wall Street
Investing.com Direct company coverage

Teladoc stock hits 52-week high at 9.78 USD

Teladoc (TDOC) stock recently hit a new 52-week high of $9.78, reflecting a significant increase of 42% in the last six months and more than doubling its 52-week low. InvestingPro analysis suggests the stock is undervalued despite being in overbought territory according to the RS

Tone
Positive 73/100
Event
Market update
Published
15 Jul 2026 15:19
Source
Investing.com
Medical Marketing and Media Direct company coverage

The NBPA taps Teladoc Health for a slam dunk way to simplify healthcare on the go

Teladoc Health has partnered with the National Basketball Players Association (NBPA) to become its preferred virtual care provider, offering comprehensive virtual health services to players and their families. This multi-year deal aims to highlight how telehealth can provide flex

Tone
Neutral 50/100
Event
Deals and strategy
Published
14 Jul 2026 17:11
Source
Medical Marketing and Media
TradingView Direct company coverage

TDOC5196025 Bond Profile — Key Metrics

This article provides a detailed profile of the TDOC5196025 bond issued by Teladoc Health, Inc. It outlines key metrics such as a 1.25% coupon rate, a maturity date of June 1, 2027, and an outstanding amount of $1.00 billion USD. The bond profile also includes information about T

Tone
Neutral 50/100
Event
Market update
Published
14 Jul 2026 04:11
Source
TradingView
ad-hoc-news.de Direct company coverage

TDOC stock holds steady as Teladoc Health builds on its telehealth base

Teladoc Health, Inc. remains a significant U.S. telehealth provider, with its TDOC stock reflecting a platform that includes virtual care, mental health services, and chronic condition management. The company's business model relies on recurring service relationships, making memb

Tone
Positive 67/100
Event
Market update
Published
12 Jul 2026 07:11
Source
ad-hoc-news.de
TradingKey Direct company coverage

Teladoc Health Inc (TDOC) Institutional Confidence

Teladoc Health Inc (TDOC) has an institutional shareholding score of 7.00, placing it 37th out of 75 in the Healthcare Providers & Services industry. The institutional shareholding proportion has increased by 20.46% quarter-over-quarter to 86.37%. James Simons is the largest inst

Tone
Positive 71/100
Event
Market update
Published
10 Jul 2026 10:41
Source
TradingKey
Market source Direct company coverage

Teladoc Health (TDOC) Stock May Be 40% Undervalued As Insurance Coverage Expands

Teladoc Health (TDOC) stock appears undervalued based on various valuation checks, with a Discounted Cash Flow (DCF) model suggesting a 39.9% discount to its intrinsic value. Despite a significant 93.9% stock decline over five years and a history of net losses, expanded insurance

Tone
Positive 71/100
Event
Balance sheet
Published
09 Jul 2026 01:41
Source
Market source
Sahm Direct company coverage

Teladoc in the Spotlight as Investors Refocus on Company's Walmart Better Care Partnership

Teladoc Health Inc. (NYSE: TDOC) shares are currently trending as investors re-examine the company's partnership with Walmart. This collaboration makes Teladoc's virtual care services, including urgent care, dermatology, and nutrition, available through Walmart's Better Care Serv

Tone
Negative 38/100
Event
Deals and strategy
Published
08 Jul 2026 22:39
Source
Sahm
Simply Wall Street Direct company coverage

Does Teladoc (TDOC) Losing Russell Growth Index Spots Recast Its Long‑Term Growth Narrative?

Teladoc Health (TDOC) was removed from several Russell growth and small-cap indexes in late June 2026 due to flat near-term sales estimates and pressure on average revenue per user. This move highlights investor concerns about its growth trajectory, despite the company's efforts

Tone
Neutral 50/100
Event
Earnings
Published
08 Jul 2026 21:39
Source
Simply Wall Street
Fierce Healthcare Direct company coverage

Teladoc Health inks multi-year virtual care deal with National Basketball Players Association

Teladoc Health has signed a multi-year agreement with the National Basketball Players Association (NBPA) to become the union's preferred virtual primary care provider. This partnership grants current and retired NBA players and their families access to Teladoc’s comprehensive vir

Tone
Positive 74/100
Event
Deals and strategy
Published
08 Jul 2026 11:40
Source
Fierce Healthcare
TradingView Direct company coverage

Teladoc Health, Inc. Stock 12‑Month Price Target Raised to $7.47, Implies 20% Downside

Teladoc Health, Inc.'s average price target has been increased to $7.47 from $7.40 based on estimates from 20 analysts, with a range of $5 to $10.50 per share. This updated target suggests a potential 20% downside from its July 6 closing price. The consensus rating for TDOC remai

Tone
Negative 35/100
Event
Analyst action
Published
07 Jul 2026 21:46
Source
TradingView
Moomoo Direct company coverage

Teladoc Health Price Target Raised to $10.50/Share From $9.00 by B of A Securities

B of A Securities has increased its price target for Teladoc Health (TDOC) to $10.50 per share, up from the previous target of $9.00. This adjustment reflects a more positive outlook on the company's stock by the analyst firm.

Tone
Positive 71/100
Event
Analyst action
Published
07 Jul 2026 11:11
Source
Moomoo
Moomoo Direct company coverage

BofA Securities Maintains Teladoc Health(TDOC.US) With Buy Rating, Raises Target Price to $10.5

BofA Securities has reiterated its Buy rating on Teladoc Health (TDOC.US) and increased the target price to $10.5. This adjustment reflects the firm's continued confidence in the telehealth provider's financial prospects and market position. The raised target price indicates an e

Tone
Positive 71/100
Event
Analyst action
Published
07 Jul 2026 11:11
Source
Moomoo
GuruFocus Direct company coverage

Insider Sell: Kelly Bliss Sells 2,500 Shares of Teladoc Health I

Kelly Bliss, President of U.S. Group Health at Teladoc Health Inc, sold 2,500 shares of the company on July 6, 2026. This transaction follows a pattern of 33 insider sells against 1 insider buy over the past year. Teladoc Health Inc is currently considered modestly overvalued bas

Tone
Negative 36/100
Event
Market update
Published
07 Jul 2026 02:09
Source
GuruFocus
Sahm Direct company coverage

Teladoc Health (TDOC) Faces Flat Sales, Is The Recent Rally Already Priced In?

Teladoc Health (TDOC) is facing scrutiny due to stagnant sales, declining average revenue per user, and flat near-term sales estimates, despite a recent rally in its stock price. While a "narrative fair value" suggests the stock is overvalued at $9.20 compared to a $7.40 estimate

Tone
Negative 40/100
Event
Earnings
Published
06 Jul 2026 21:39
Source
Sahm
Stock Titan Direct company coverage

Teladoc (TDOC) CAO sells shares after RSU vesting for tax withholding

Teladoc Health, Inc.'s Chief Accounting Officer, Joseph Ronald Catapano, reported a sale of 653 common shares at $9.10 each on July 2, 2026, to cover the tax withholding obligation from the vesting of 2,083 restricted stock units (RSUs) on July 1, 2026. These RSUs were part of a

Tone
Neutral 50/100
Event
Market update
Published
06 Jul 2026 20:09
Source
Stock Titan
Investing.com Direct company coverage

Teladoc Health CAO sells $5,942 in common stock

Teladoc Health's Chief Accounting Officer, Joseph Ronald Catapano, sold 653 shares of company common stock for $5,942 to cover tax withholding obligations associated with RSU vestings. This transaction occurred on July 2, 2026, after 2,083 restricted stock units converted to comm

Tone
Neutral 50/100
Event
Market update
Published
06 Jul 2026 20:09
Source
Investing.com
Stock Titan Direct company coverage

Teladoc (TDOC) executive Kelly Bliss sells 2,500 shares under 10b5-1 plan

Teladoc Health, Inc. executive Kelly Bliss, President of U.S. Group Health, sold 2,500 shares of Teladoc common stock at $9.50 per share. This transaction was conducted under a pre-arranged Rule 10b5-1 trading plan adopted on August 14, 2025. Following this sale, Bliss directly h

Tone
Negative 36/100
Event
Market update
Published
06 Jul 2026 19:09
Source
Stock Titan
Stock Titan Direct company coverage

TDOC (TDOC) Form 144: Director sales and proposed resale of 2,500 shares

Teladoc Health, Inc. (TDOC) has filed a Form 144 notice disclosing a proposed resale of 2,500 shares of common stock stemming from restricted stock vesting dated March 19, 2025. The filing also details three recent open-market sales by Kelly M. Bliss on June 2, June 29, and July

Tone
Neutral 50/100
Event
Market update
Published
06 Jul 2026 17:42
Source
Stock Titan
Stock Titan Direct company coverage

Teladoc gives new BetterHelp product chief 50,000 shares

Teladoc Health (NYSE: TDOC) has granted 50,000 restricted stock units to David Packles, the new Head of Product for BetterHelp, effective July 1, 2026. These RSUs will vest one-third after one year, with the remainder vesting quarterly over the subsequent two years. This induceme

Tone
Positive 63/100
Event
Market update
Published
03 Jul 2026 20:40
Source
Stock Titan